InvestorsHub Logo
Followers 3
Posts 77
Boards Moderated 0
Alias Born 04/03/2014

Re: investinthefuture post# 23873

Wednesday, 07/01/2015 2:01:34 PM

Wednesday, July 01, 2015 2:01:34 PM

Post# of 140464
Surgical robot heavy Secret: price, profit, application sections, the largest player in the full resolution!
2015-07-01 CRE in the small cap research team Comments (0)
Untitled -10.jpg

Intelligence is the new direction of medical hardware industry. We propose "intelligent medical hardware" investment theme, and that the topic will be following the "personalized medicine / Precision medical care" after twelve domestic market in the pharmaceutical sector in the next three to five years, significant investment opportunities. We define "intelligent medical hardware" as, with advanced software technology and big data with a new generation of hardware technology, innovation of traditional medical equipment or upgrading of a new generation of medical applications.

We will be on the "intelligent medical hardware" topic, according to the Chinese market development and integration of industry information filter, launched a series of studies of medical equipment segments. Topics of this issue can best represent the latest trends in healthcare medical robotic intelligent medical one hardware.

Robotic applications in the medical field received extensive attention. At present, the application of robotics in the medical profession about the main focus on the surgical robot, rehabilitation robot, nursing robots and service robots. Among them, the surgical robot is currently the most widely used and most prospects, its powerful features provided to overcome the traditional surgery poor accuracy, the operation time is too long, the doctor fatigue, and lack of precision three-dimensional vision and other issues.

Surgical robot will change the pattern of traditional medicine. Minimally invasive surgery is the medical profession in the past 30 years has been pursuing the topic. Minimally invasive surgery to make people see the bright future of minimally invasive surgery. When the 2000 launch of the da Vinci surgical robot (da Vinci) system is excellent clinical results, but also for the future of medical intelligence, minimally invasive, precise technology development laid an important tone. With the upgrading of robotic surgery and continue to improve in the near future will promote significant reform the health care system.

US IntuitiveSurgical companies dominate the global market. The company's da Vinci surgical robot system launched in overseas secondary market caused a sensation. IntuitiveSurgical company's share price from $ 10 to market, and in May 2012 rose to the highest price of $ 588, or up to 58.8-fold. By the end of 2014, the global total installed capacity of da Vinci 3266 units, the domestic introduction of price up to 20 million yuan. Not only surgical robot system has only vast sales market, there is even more potential to change the rules of the medical profession, it is an important strategic weapon in the medical field next layout.

China will usher in significant growth opportunities in the surgical robot boom. China's current market reached 850 million by 2018 will be 1.57 billion. With the domestic policy to encourage the development of high-tech medical equipment intensive introduction in recent years, and the Institute of domestic self-developed and efficient progress, the situation in our country will hopefully break the monopoly of imported surgical robot. Surgical robot industry chain will also bring opportunities for domestic enterprises, has the potential from the dealer, supplies and maintenance, the robot operator training services, and even aspects of operation outsourcing services into the market.

Research on Logic

1. What is the surgical robot?

Robot motion with high precision set, and can stable operation and accurate processing of data. Robots in the medical field can be better instead of doctors who have completed part of the mission by a computer control technology. At present, the application of robotics in the medical profession about the main focus on the surgical robot, rehabilitation robot, nursing robots and service robots. Among them, the surgical robot is currently the most widely used and most prospects, its powerful features provided to overcome the traditional surgery poor accuracy, the operation time is too long, the doctor fatigue, and lack of precision three-dimensional vision and other issues. Surgical robot is a medicine , mechanics, biomechanics, computer vision, artificial intelligence, and many other new interdisciplinary research area.

1.1 surgical robot development history

In 1985, the first time in medical robotics is used for surgery. PUMA560 robot was using industrial robots. Doctors use it to complete the guidelines brain biopsy probe and were later improved after transurethral resection. However, because of safety problems, the robot no further promotion.

In 1987, the first cases of minimally invasive laparoscopic surgery successfully after the public began to minimally invasive surgery (Minimal Invasive Surgery) demands continue to increase, more and more areas of minimally invasive surgical procedure to replace the traditional surgery. However, laparoscopic surgery obvious defects, such as doctors need to hold a mirror assisted surgery, the loss of three-dimensional visual and tactile, the instrument is too long and the fulcrum effect leads to poor flexibility.

Minimally invasive surgical robot research boom kicked off in the 1990s. In 1994, the first surgical robot holding a mirror from the US company Computer Motion Aesop (AESOP) appears. Aesop has a virtual joint (7 degrees of freedom), to receive the surgeon's voice commands or foot controls to adjust the position of the laparoscope, but can not perform surgical procedures independence. By the end of 1999, AESOP surgical 80,000 cases have been completed.

1996 ComputerMotion upgraded version of the second generation of the company robot Zeus (ZEUS) available, use hand operation mode, the three arm, coefficient console and computer controller. Doctors available voice controlled manipulation of laparoscopic arm and hand operated two other surgical operations arm surgery. Zeus received the European CE certification market in 1999, and completed remote cholecystectomy in 2001.

1999 IntuitiveSurgical's first generation da Vinci surgical robot (da Vinci Standard) developed. In the basic mode of Zeus, based on its excellent ergonomic design, high performance vision systems and proprietary technology in the wrist completed the initial shape of the surgical robot. In July 2000, the US FDA approved the da Vinci system became the first legally allowed commercialization for clinical use in a surgical robot. The company in June 2000 listed on NASDAQ. 2003, Intuitive Surgical Company completed the acquisition of the company Computer Motion, which began exclusive surgical robotics market, the global robot market share has reached a total of more than 50%.

In 2006, the second generation of Da Vinci system (daVinciS) appears, has four robotic arm and HD 3D HD endoscopes. 2009 third-generation da Vinci system (da Vinci Si) further escalation, with two master-slave relationship between doctors console, the surgical guide more convenient, and the use of advanced high-definition visualization technology, up to 10 times magnification.

The latest generation of the fourth generation of the da Vinci system (da Vinci Xi) on April 1, 2014 was approved by the US Food and Drug Administration put into use. In addition to upgrading the robotic arm accuracy and operating range, the new generation of the da Vinci system also has a laser positioning, and make more flexible the four minimally invasive surgical swivel bracket new designs. The new system scalability strengthen, make a series of imaging systems and instrument technology seamlessly. University of Miami Sylvester Cancer Center was officially put into use in the fourth generation of the da Vinci system, but the market's first three generations of the da Vinci system is still dominant.

Untitled -4.jpg

Figure 1: The fourth generation of the da Vinci system (da Vinci Xi) schematic

In this paper, the most mature technology, the world's most widely-assisted da Vinci surgical robot system as the main reference for minimally invasive surgical robot investment market analysis.

1.2 da Vinci surgical robot system

Da Vinci surgical robot system is assisted by a surgical robot system robot giant IntuitiveSurgical global medical research and development, is currently the world's only robotic surgical system can be formally approved for use in hospital surgery.

Da Vinci surgical robot system consists of three parts: 1 Doctor console, two three-dimensional imaging video imaging system, a plurality of 3 arm, the camera arm and surgical instruments, consisting of mobile platforms... Doctors can sit in front of the console away from the operating table to obtain three-dimensional vision of the surgical patient target position around the video image directly through the three-dimensional imaging system, and manipulate the robotic arm to complete the operation by hand movements senses.

The latest generation of "Da Vinci" surgical robot arm a total of four, one for the camera arm, the other three can be flexible conversion procedure to be a separator, tweezers, ultrasonic knives. The imaging system built robot core processor and image processing equipment, combined with 3D camera arm, the patient can show high-definition 3D images for doctors, so the surgeon to complete the operation by the robotic arm accurately. Da Vinci surgical robot system breaks through the limitations of traditional surgery surgical field and in vivo operating angle, reaching beyond the reach of traditional surgery minimally invasive, precise degree. Currently, the da Vinci Surgical System is the world competing with hospitals, successfully applied to general surgery for adults and children, thoracic surgery, urology, gynecology, head and neck surgery and heart surgery.

Untitled -5.jpg

Figure 2: a schematic view of the da Vinci system operation

For the surgeon, the DaVinci surgical robot system characterized by:

(1) providing a three-dimensional surgical field, clear operation target position ready position.

Wrist joint (2) having a plurality of surgical instruments on freedom of movement, more flexible, expand the operational capability of the surgical team, improve surgical precision, and can eliminate unnecessary vibration, breakthrough surgical operating space limitations.

(3) personal surgeon to complete a television laparoscopic surgical team work, optimization of human resources.

(4) The surgeon physicians take sitting for system operation, it is conducive to long complex surgery.

For patients, DaVinci surgical robot system characterized by:

(1) minimally invasive surgery to minimize wound (single wound diameter 25px),

(2) the need for surgery to reduce blood loss or transfusion;

(3) to reduce the demand and the risk of infection anesthesia;

(4) shorten recovery time, reduce the number of days of hospitalization.

Therefore, the surgical robotic system for minimally invasive surgery is absolutely revolutionary innovation, not only reduces a greater degree of surgical trauma, improves the efficiency of doctors, more importantly, improved surgical results, in order to promote minimally invasive Surgical advances offer more possibilities.

1.3 surgical robot industry bottleneck

Surgical robot industry experience constraints in major technical defects, management applications, and the use of high cost three.

Technical defects

Anaphia it impossible to distinguish tissue toughness and touch vascular pulsation, temperature leads to loss of sensation can not distinguish different tissue temperature differences.

Lack of fine motor grip and pressure feedback system.

Management Applications

The robotic surgical system is not able to be applied to all surgery, particularly complex, difficult some surgery.

The robotic surgical system requires doctors to have some surgeon surgery clinical experience and through hands-on training.

Perfect quality control system, quality control equipment specifications require third-party testing and certification organization.

Robotic surgery is currently not included in the health care system, patients have no small financial burden.

High cost

High maintenance costs, the surgical robot is generally required every 3-4 months to conduct a maintenance, maintenance.

Equipment is expensive, the price in China up to 20 million yuan or so.

Supplies expensive surgical instruments and equipment is a consumable supplies, each use is limited to 10 times, and each operation requires the use of three to four. Each supplies equipment prices as high as 3.6 to 42,000 yuan, which means that every time a robotic surgical supplies will be more than cost about 10,000 yuan.

Surgery is expensive, the cost of expensive than ordinary surgical 2-3 million yuan.

1.4 surgical robot future direction: personalized, remote, intelligent

Direction of minimally invasive surgical robot technology development can mainly reflected in the following three technical branches in: Workspace analysis and route planning systems, virtual reality surgery system and interactive systems.

Workspace analysis and route planning systems: Personalized

In using robotic surgery to make, instruments in the patient motivated speed, the range of movement needs to be more accurately calculated. When a plurality of arm co-operation, if the path to achieve coordination is especially important in a small space without disturbing each other. Therefore, improving the work of spatial analysis and route planning to improve operation efficiency and safety. Future Technology goal is to preoperative surgical navigation system information and combine to make the surgical procedure can be accurately complete the work space and the path is automatically determined. Future surgery will tend to personalize, doctors say will dig image solution patient according to edit operative procedures, surgery and then issue simply monitor the operation instruction after surgery is completed.

Virtual Reality Surgical System: remoting

The virtual reality technology integration of great importance such as medicine. Future virtual reality technology allows the surgeon to complete the operation in the case of remote control. As early as 2001, the United States, France has completed the world's first remote transoceanic cholecystectomy. Our cooperation from the Navy General Hospital, Beijing and Shenyang Hospital in 2003, completed the country's first remote remote robotic surgery. The future development of surgical robot will make communication and cooperation between the surgeon becomes smooth helpless, making the global medical technology rapidly increasing.

HMI system: Intelligent

Force Feedback Research and development can make a machine interaction system further improved. Join fine motor power feedback not only can enhance the surgeon's operating precision, physicians can also provide tips and alarm operation through software settings, the surgical robot more intelligent.

2, surgical robot global market

2.1 global medical device market size and steady growth in R & D investment

According EvaluateMedTech statistics, the global medical device market in 2007 from $ 272 billion in 2014 to grow to $ 380 billion. According to projections, by 2013 - a compound annual growth rate between 2020 to 5% of the global market will reach $ 514 billion in 2020. Among them, the global medical device R & D investment will be $ 23.8 billion in 2014 to reach $ 30.5 billion in 2020, its compound annual growth rate of 4.2%. Market size and global medical device R & D investment will continue to grow steadily improve the existing level of medical care. Surgical robots as the future direction of the evolution of medical devices will usher challenges and opportunities.

2.2 global medical robotics will reach $ 3.764 billion in 2018

According to MarketsandMarkets company's 2014 research report, the global medical robotics market in 2013 was $ 1.781 billion, expected to reach $ 3.764 billion in 2018, a CAGR of 16.1%. Among them, the surgical robot about 60% market share. The report said the current North American market is the largest market, and because the government increased spending on health care, the health care system restructuring and strengthening people's awareness of minimally invasive surgery, the future market focus will gradually shift to the Asian market.

Intuitive Surgical, Inc. 2.3 United States dominate the global market

Leonardo da Vinci Surgical System appears to change the pattern of the traditional surgery, the surgical reshaping of the US market. Below is obstetrics and gynecology and urology surgery type scale drawing. Visible during the da Vinci Surgical System appears 10 years have changed the pattern of traditional surgery, which is an increasingly important position in the medical profession.

Untitled -6.jpg

Figure 3: Leonardo da Vinci in the proportion of obstetrics and urology surgical evolution diagram

Intuitive Surgical Company was established in 1995, listed in 2000, became profitable in 2004. The share price from $ 10 to market, and in May 2012 rose to the highest price of $ 588, or up to 58.8-fold. As of June 22, 2015, Intuitive Surgical company's share price was $ 499.45, the total share capital of 36,599,800, market capitalization reached 18.28 billion US dollars, equivalent to RMB 113.336 billion.

Intuitive Surgical Company's financial performance over the past decade is also very alarming. The company's revenue compound annual growth rate of 41%, higher net profit growth, gross margins are on the rise which, starting in 2008, gross margin over 70%. According to IFR statistics, mid-2013 the global medical robot sales of about 1.45 billion US dollars, about 8.7 billion yuan, which accounted for more than 50% of the da Vinci system whole medical robotics market share.

According to official 2014 report INTUITIVESURGICAL, Leonardo da Vinci surgery system was about 570,000, compared to 523,000 cases in 2012 and 450,000 cases of steady growth in 2013. Major surgical volume growth in 2014 came from the United States, general surgical and urological surgery worldwide. 2014 total operation except the United States is 121,000, an increase of 19.8%, well above the total operation grew 9.0% Figure 4: Total Leonardo da Vinci Surgical System 2009-2015 data.

Untitled -7.jpg

Da Vinci system generally priced at 3.72 million yuan according to geographical location between 15.5 million yuan. IntuitiveSurgical company's turnover also comes from supplies and maintenance, which contracted maintenance costs depending on the model year for 62-1050000 yuan. 2014 annual turnover of over 13 billion yuan. Income which brought supplies and maintenance costs presented Bidafenqi system faster sales growth.

Da Vinci system in 2014 sold a total of 431 units, while sales in 2013 to 546 units. As of December 31, 2014, the da Vinci system global reach 3,266 units, of which 2223 in the US, Europe has 549 Taiwan, Japan has 193 units, the rest have 301 units. Decline in systems sales occur in Japan. The Chinese side, INTUITIVE SURGICAL 2014 Annual Report attitude optimistic that sales will follow the trend of steadily rising in previous years.

Untitled -8.jpg

Figure 5: Global sales of the da Vinci system in 2013 and the four quarters of 2014

By the end of 2014, the global total installed capacity of 3266 da Vinci robot units, of which the United States 2223 Taiwan, Europe, Taiwan 549, 350 in Asia, the Mainland of China a total of 29 units, including nine in Beijing. According to incomplete statistics, China currently has about 30 medical institutions in the introduction of the da Vinci surgical robot 34, Hong Kong also has eight da Vinci surgical robot.

2.4 Other surgical robot company

Intuitive Surgical's da Vinci system is a huge advantage, basically completed the surgical robot market rule. Leonardo da Vinci Surgical System has been used in general surgery, thoracic surgery, urology, gynecology, head and neck surgery and heart surgery and other fields, the superiority of their products in these areas it currently can not be replaced.

Untitled -9.jpg

Figure 6: da Vinci Surgical System operated by the current FDA approved

At present most of the other companies or institutions to develop a robot turning their attention to the field of da Vinci surgical system is temporarily not occupied, such as ophthalmology, neurosurgery, and orthopedics. Johns Hopkins University developed a robot for minimally invasive vitreoretinal Steady-Hand in 2007. ZTH Zurich ophthalmic surgical latest wireless micro robotic system being developed. ImperialCollege London recently studied a new robot probe skull perforation for neurosurgery. ROBODOC robot system by the IBM Research Center and the University of California research team has developed for orthopedic total hip replacement surgery in 2008 by the FDA, and constantly update perfected. However, the above-mentioned specialized surgical robot market is small, expensive equipment and significant technical defects so that they could not receive special attention in the market.

Canadian TitanMedical company is developing its equipment SPORT system tries to small, low prices and other advantages of self-developed patent challenge the dominance Duffing system. SPORT system aimed at the general surgery, gynecology and urology fields, with single-hole equipment design patents, the use of the platform flexible, small footprint and low cost (less than $ 1 million) strategy to enter the market. Titan Medical company plans to obtain FDA approval in 2017 and sold in the United States. Then the lack of funds and time-consuming research and other factors make it no room to deal with delays or other emergency equipment approval, prospects remains to be seen. Its share price from 2.19 US dollars September 30, 2014 fell to 1.34 dollars (23 June 2015).

3. Why robot surgery abroad at this time to cross the threshold?

3.1 intelligent medical hardware is a global health trend

When the "Internet +" and "big data" in China limelight Masamori, the US has gradually started the "intelligent hardware era." It has a strong software technology and a large data base, when the Internet and software technology giants already have started to intelligent hardware layout.

Following Amazon's electronic reader unmanned aircraft research and development investments. Google to create the Google glasses and driverless cars. Facebook plans to launch a series of "virtual world" experience devices. Apple in order to consolidate its position in the launch of intelligent hardware Apple Smart Watch. Intelligent hardware representative 3D printer, intelligent robots, and Tesla pure electric vehicles is familiar to everyone.

"Intelligent Medical Hardware" is the future trend of development of medical devices, a number of domestic and foreign giant companies have a smart health hardware business layout. Throughout history, advances in emerging technologies inevitably reflected in the development of the medical industry. The arrival of "intelligent hardware era" promote the development of artificial intelligence technology, not just the improvement in the improvement of people's life, but also the medical side created more far-reaching value.

A number of foreign companies have a card giant intelligent medical hardware. Apple is to create medical hardware products, and actively develop the sensor technology can predict heart disease. Google and Johnson & Johnson's Ethicon medical device company in March this year announced a strategic cooperation agreement to jointly promote to create a new platform for robotic-assisted surgery. Intel company through the acquisition of new technologies into the chip Basis Surgical Science in medical monitoring equipment.

Domestic BAT (Baidu, Alibaba, Tencent) three Internet giants to enter the medical device field. Ali Baba and Foxconn Technology Group announced on June 18 to Softbank robot holding company inject 732 million yuan, to develop and expand the robot industry, intends to enter the health care field.

3.2 intelligent medical hardware supported by national policy, is expected to quickly develop

It is reported that " the pharmaceutical industry "Thirteen Five" development plan "(the" Plan ") will be prepared this year to complete. Has been determined based on the idea, biomedicine and high-performance medical instrument is determined to achieve breakthroughs in key areas. According to incomplete statistics, China has a medical device manufacturer about 15,000, but 90% of the enterprise income scale less than 2,000 yuan. In the current high-end medical equipment medical institutions basically monopolized by foreign products. During the "Thirteen Five", the National Development for the medical device industry will be more attention and support. Medical device companies face challenges industry reconstruction, the relevant departments or introduce more policies to support the development of high-performance medical equipment, medical equipment, innovation will be the market focus.

3.3 surgical robot will turn the domestic market in 2018 nearly doubled

In early 2013, under the Health Planning Commission issued a document "2013--2015 National endoscopic surgical instrument control system configuration planning" to define the configuration of the surgical robot standards in public and non-public medical institutions. According to plan content forecast to 2018 the country will have a total of 90 hospitals to purchase equipment Da Vinci system. Press Currently 50 hospitals in 34 standard purchase the da Vinci system and 80% market share estimates, China's current surgical robotics market is 850 million yuan. Assume the da Vinci system in 2018 acquired 70% rate and the 80% market share estimates, the domestic market in 2018 will be 1.57 billion.

3.4 surgical robot at home and abroad in the early development phase or clinical trial

2003, Beijing University of Aeronautics and Astronautics, Tsinghua University, Navy General Hospital developed "Li Yuan" robot system is the first with independent control, a new generation of visual positioning and remote control functions of minimally invasive surgical robotic surgical system.

December 2013, Harbin Institute of Technology announced that China's independent intellectual property rights of celiac minimally invasive surgical robot formally completed. The results of surgical robot systems in the mechanical design, the master-slave control mechanism, laparoscopic and other three-dimensional vision of the breakthrough in key technologies.

March 2014, the domestic self-developed "Cherish S" robot Xiangya Hospital successfully completed the first domestic-made robotic surgery. "Cherish S" technological superiority embodied in the decoupling much design freedom wire transmission technology to test the flexibility to precisely operate in tight spaces. "Cherish S" small, low-cost advantages of its da Vinci system has the potential to become a competitor in the country.

3.5 surgical robotics decomposition and technical barriers

Doctors console as a control core computing into the system by the operating handle and monitors and other components. Surgeon by the wrist and finger movements, passing through the computer signal, manipulation of surgical instruments, mechanical arm surgery. While complete power cut, coagulation and other operations with a foot pedal. Human-computer interaction design core computer operating system, the core technology is the mechanical sensor to accurately grasp the subtle movements of a human finger.

Three-dimensional imaging video imaging system provides the surgeon the results of patient anatomy realistic 3D vision, and through the large-screen video system allows the entire surgical team findings. The core technology is HD 3D endoscope.

A plurality of arm, arm mobile platform camera and surgical instruments for reception command physician patient minimally invasive surgery. When the robotic surgery, the first hit in the chest or abdominal wall several 25px diameter holes, mechanical arm into the body operating the patient. Mechanical arms and core technologies that enable the built-in wrist device, the difficulty lies not only to imitate human behavior subtle movements of the arm and can move in a narrow range than the human wrist movement space experiments wider angle. In the design of the core and the path a plurality of mechanical arms designed to ensure the movement trajectory interfering.

3.6 surgical robot industry segments to domestic enterprises opportunities

Surgical robot is different from other medical devices, to change the rules of the medical profession potential of its existence. Future promotion surgical robot will cause some devices to be eliminated and redesigned, it is likely to change now that many segments of the medical industry's business model. Research market segments need to chain research. Surgical robot chain can in turn divided into equipment development, supplies and maintenance and training services for doctors from upstream to downstream. Domestic enterprises have the opportunity to gradually and overseas giants compete by market segments.

Equipment R & D

Equipment end domestic market monopolized by foreign companies. The main technical barriers to the da Vinci system mainly in the high degree of freedom of mechanical wrist design, high-definition endoscopic imaging equipment and computer integrated control system design. Innovative breakthrough surgical robot needs to be able to complete the surgery some doctors can not be completed. Surgical robot as a set of multiple technologies in a systematic equipment, innovative medical design is more important than engineering technology. Domestic surgical robot research and development projects, mainly in engineering and technology research and development laboratories of major universities, and foreign top team more in the medical research center or top University School of Medicine. Domestic enterprises can be established through the recruitment of top talent overseas medical engineering team have fully comprehensive knowledge of independent research and development.

Dealer

Surgical robot system of the current clinical use of all from imports. Dealer as foreign companies in the country which sells the bridge will have a certain market share. Dealers as an intermediary, in addition to a qualified related hospital sales, it can also set up overseas and domestic firms supply maintenance, equipment and technical guidance platform with domestic supplies firm cooperation.

Supplies and maintenance

IntuitiveSurgical mentioned above the company's profit more from the maintenance of supplies and equipment, and in 2014 was 9.3 billion yuan. The latest generation of Leonardo da Vinci Surgical System robot arm can perform a variety of surgical instruments and imaging equipment seamless connectivity. Domestic surgical instruments company may be able to achieve cooperation in Intuitive Surgical instruments in a series of surgical instruments used arm, which occupy a certain market share.

Da Vinci system maintenance costs by 34 units systems currently calculated as 27.2 million yuan a year market, after three years to reach 50.4 million yuan. Domestic company can take the contractor to enter the segment of cooperation.

Robot Operator Training Services

DaVinci operating system requires a doctor some time training to skilled grasp. Operating losses during exercise can cause the instrument, and as expensive supplies and equipment costs are so high that the da Vinci system training costs high. Domestic companies through the development of human-computer interaction and analog simulation software operating systems and other services for physician services demand.

Surgery Outsourcing

Promotion surgical robot may break the existing medical business model. Future hospital may be more users diagnose, and robotic surgery may be outsourced to specialized companies. Surgical robot is not only profitable products, but also can be used as the layout of the future strategy for the medical market products.

4, domestic business companies involved in medical robot

4.1 Listed Companies

A, robot

(1) Company Profile

Shenyang New Song Robot & Automation Co., Ltd. was established in 2000, listed in 2009, made by the CAS Shenyang Institute of Automation main sponsor. The company is a company with independent intellectual property rights of industrial robots and automation of complete sets of equipment suppliers, the main products include industrial robots, logistics and warehousing automation of complete sets of equipment, automated assembly and test production line, transportation automation systems. Our products can be widely used in automobile and auto parts, engineering machinery, rail transportation, low-voltage electrical appliances, electrical, IC equipment, military, tobacco, banking, pharmaceuticals, metallurgy, and printing and publishing industries.

(2) Medical robot layout

Shenyang New Song Robot companies use their own advantages in the field of robotics, the robot has been in the accompanying orthopedic surgical robot and robot-assisted diagnosis and treatment aspects mirror layout.

Chaperone robots.

Shenyang New Song Robot's escort robot currently mainly for nursing home and community services. Its functions are the physiological signal detection, voice interaction, telemedicine, smart chat, autonomous obstacle avoidance roaming. We can take care of the full range of user needs in life care, remote communication and health care aspects. Chat with intelligent robot that can assist the elderly psychological rehabilitation. With the relevant testing equipment, robots have blood pressure, heart rate, blood oxygen and other physiological signal detection and monitoring function, the wireless network to connect communities and transmitted to community health centers, emergency situations can be a timely warning or notice their loved ones. Major social problems accompanying aging populations robots provide solutions.

The robot broke the robot voice recognition and interactive algorithms, network sensing and multi-sensor data fusion, robot-assisted elderly psychological rehabilitation, Wi-Fi and other remote monitoring and control of a number of key technologies. And applied for telemedicine capabilities art patents in 2012. Currently belongs to the demonstration application stage.

Orthopedics auxiliary robot.

New Song Robot Company and in 2013 developed the first robot of Orthopedics and to produce a test machine. Orthopedics robot using a robot system towing patients injured area fixed traction, improves traction stability. Re-use a robotic arm during surgery and traction surgical site in real-time feedback holographic images allow doctors to better plan the whole operation, strengthen the doctor fracture traction judgment. Finally the robot system to help doctors perform precise traction fracture site to help patients reset the fracture.

The company has seven orthopedic robotics patents, and in the application of medical equipment production license.

Endoscopic diagnosis and treatment of assisted robot systems.

Endoscopic diagnosis and treatment of assisted robot system is one of the topics five "National Science and Technology Support Program." Endoscopic diagnosis and treatment is the first international robot-assisted system with independent intellectual property rights for our 80 million gastrointestinal illnesses huge demand for endoscopic diagnosis and therapy, and lead to a serious shortage of trained doctors and supply demand relationship undertaken research and development.

Currently, the issue technological breakthrough in the endoscopic delivery, tumor lesions recognition algorithms, high-performance power integrated multi-frequency power system building three key technologies; develop a flexible endoscope lens body transport unit, neoplastic lesions recognition module, more power integration The high-frequency power system, the core components; complete system prototype robot-assisted endoscopic tumor diagnosis software systems and endoscopic argon plasma coagulation device prototype development.

B, Hiromi Shares

(1) Company Profile

Harbin Boshi Automation Co., Ltd. was founded in 1997, listed in 2012. Harbin Institute of Technology by the Institute of Robotics main sponsor, Bo is currently automation HIT investment remains the largest shareholder. The company is the petrochemical, chemical processing equipment after the development, production and sales, and related products and services to provide customers with integrated automation solutions. Because the existing petrochemical industry outlook downward pressure, the company actively develop the future strategic direction and objectives, to promote R & D and investment in robotics technology as the representative of high-end medical equipment field.

May 11, 2015, the company decided to set up a wholly-owned subsidiary of Boshi high-end medical equipment Co., Ltd. invested 100 million yuan and to 20 million in cash to subscribe for Esprit Turbo health equity. It plans to invest "minimally invasive surgical robot and intelligent devices Project" through a medical equipment company.

(2) Medical robot layout

Bo is on high-end automation will target medical robots, and HIT and affiliates Esprit Turbo medical research and development of minimally invasive surgical robot, the target break da Vinci in the domestic monopoly.

Minimally invasive surgical robot.

"863" program funded projects - "minimally invasive intraperitoneal surgical robot system", it has successfully developed in 2013 by the Harbin Institute of Robotics and through the national "863" expert group acceptance. The robot was developed jointly by HIT and Esprit Turbo medical care. The da Vinci robotic system similar to the system, by the arm, three-dimensional imaging systems and physician control console. So that doctors can be in the console by definition three-dimensional imaging systems and force feedback remote patient minimally invasive surgery. At present, the robot can be used now minimally invasive surgical separation of the abdominal cavity, cutting, bleeding, suturing and other basic movements. Generation has completed several batches of animal experiments. The second-generation products has been completed products stereotypes, the assemblage model machine. Is expected by the end of 2015 can apply for the product in the form of test preparation, and application products in the end of 2017 registered.

C, Chutian Technology

(1) Company Profile

Chutian Technology Co., Ltd. was established in 2002, listed on the Shenzhen Stock Exchange in 2014, GEM. The company agent class pharmaceutical equipment development, design, production, sales and services for the main business. Agent class pharmaceutical equipment is the key to pharmaceutical companies to produce injection preparations. The company's future layout medicine and medical robotic robot. Using intelligent robot market will rapidly enlarge to complete industrial transformation and upgrading of the company.

(2) Medical robot layout

Chutian Technology use their own experience in the pharmaceutical agent class of equipment, to improve, by the end of 2015 plans to launch pharmaceutical aseptic packaging robots.

Medical robotics, Chutian scientific and technological cooperation with the National Defense University, Central South University and Huazhong University of Science and Technology. Will exoskeleton robotics research as a starting point, mainly for the disabled and the elderly take care of themselves, play a supporting role, while the military weight class robots can be used in areas such as the National Defense University is responsible for fielding the declaration.

D, Dimagufen

Dimagufen on April 1, 2015 signed a research agreement with the University of Electronic Science and Technology to jointly develop the exoskeleton robot.

E, Hai Sike

Hai Sike on June 25, 2015 announcement, shares of the company Haisight $ 10.5 million will be used to subscribe for 174,993 shares MST preferred shares, accounting for 26.66% of the fully diluted equity basis.

MST is in Israel's leading medical device research and development company whose main product is "AutoLap", one kind of image guided laparoscopic surgery laparoscopic intelligent positioning device that can become a doctor, "his third hand." AutoLap global leader in technology, the medical field has the world's only real-time image-guided positioning system, products have been the United States Food and Drug Administration (FDA) and CE certification. MST program in the near future to apply for Chinese Food and Drug Administration (CFDA) certification. Autolap global market opportunities more than 3 billion US dollars, is expected in 2018 to more than 5 billion US dollars.

According to relevant agreements, Hai Sike will get "AutoLap" 15 years of exclusive sales agency in China, is expected to bring a significant upgrade to the company's future performance.

4.2 unlisted domestic medical robotics company

A, Cherish Robot Technology Group

(1) Company Profile

Nanjing Cherish Robot Technology Group was established in 2012, is one of 321 people in Nanjing plans to support start-ups. The company specializes in providing intelligent mechatronics, robotics and digital products manufacturing equipment; areas of concern are: medical services, industrial production, manufacturing and processing, transport, and smart city. The company main products are medical and research robot-assisted surgery, industrial robots, service robots and science robots.

(2) Medical robot layout

Cherish robot company committed to the development of high-end minimally invasive surgical robotic systems, aimed at breaking the monopoly of da Vinci surgical robot system. Company and Tianjin University to develop "Cherish robotic system," the State 863 Program and the National Outstanding Youth Science Fund to support the project, has entered the clinical testing stage. The robot has four degrees of freedom of the United States SensAble Corporation 6 PHANTOM? DESKTOP arm, three-dimensional imaging devices, and gravity sensing console. Cherish S has partnered with Third Xiangya Hospital, Central South University, has for three patients had a gastric perforation repair and appendectomy. Surgery went smoothly, patients recovered well. And it is expected to put into use in three years.

B, Chongqing Jinshan Science and Technology Co., Ltd.

(1) Company Profile

Chongqing Jinshan Science and Technology Co., Ltd. was established in 1998, it is one of the top 50 most development potential of China's private enterprises. The company is set digital medical equipment research and development, production, sales and service in one of the national high-tech enterprises. Its main products include endoscopy, capsule robots, electrical impedance imaging.

(2) Medical robot layout

Capsule robot

Jinshan Science and Technology developed the world's first "capsule robot." The traditional oral capsule endoscopy capsule camera with built-in intelligence signal transmission device, with enterokinesis make movement and capture images in the digestive tract. However, the traditional capsule endoscopy can only help the digestive tract motility, unable to stomach were complete and accurate observation. The capsule robot can allow doctors through in vitro "capsule endoscopy attitude controller" control patient capsule movement to realize the stomach and digestive tract and other large comprehensive examination.

Surgical robot system

Jinshan Science and Technology currently has distribution surgical robot systems, developed minimally invasive surgical robot is expected to be in July 2015 to conduct clinical trials in several hospitals in Chongqing. The robot system consists of three-dimensional imaging systems, mechanical surgery arm and touch sensing operation table.

C, Shenzhen Sang Valley Technology Co., Ltd.

(1) Company Profile

Shenzhen Sang Valley Medical Robotics Ltd. was established in 2003, Shenzhen City Robot Association, Silver Star Group, a subsidiary of the national high-tech enterprises. Currently engaged in professional development and application of intelligent medical robotics, production, operation and marketing. The company's products have set cleaning robots, and medical robots.

(2) Medical robot layout

Sang Valley Medical Robotics and the US Robotics invented the world's leading manufacturer of China's first intelligent robot intravenous pharmaceutical formulation and manufacturing plants -Unmaion company SUST affiliated hospitals. The robot can be used in hospital outpatient chemotherapy department, infectious diseases, total parenteral nutrition and liquid purification of pharmaceuticals. Robot robot is the entire work process without touching the liquid using a sterile transfer the operating system in a clean room environment of space, configure automatic medication to ensure that the preparation of an infusion of sterility, compatibility, stability, and reduce particulate pollution. But also effectively prevent contamination of the surrounding environment in the preparation of cytotoxic drugs are brought to improve the safety of clinical rational use of drugs.

In order to facilitate your visit to the Valley Medical Supply, Medical Valley can focus on the Micro Signal: yigoonet or add friends in the micro-channel direct search "Medical Valley," plus interest.